2015
DOI: 10.1002/bdd.1929
|View full text |Cite
|
Sign up to set email alerts
|

In vitro metabolism of an estrogen‐related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s

Abstract: GSK5182 (4-[(Z)-1-[4-(2-dimethylaminoethyloxy)phenyl]-hydroxy-2-phenylpent-1-enyl]phenol) is a specific inverse agonist for estrogen-related receptor γ, a member of the orphan nuclear receptor family that has important functions in development and homeostasis. This study was performed to elucidate the metabolites of GSK5182 and to characterize the enzymes involved in its metabolism. Incubation of human liver microsomes with GSK5182 in the presence of NADPH resulted in the formation of three metabolites, M1, M2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
14
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 27 publications
(39 reference statements)
0
14
0
Order By: Relevance
“…Nowadays, human liver microsomes (HLMs) are commonly used in in vitro drug metabolic studies with advantages of high probability of clinical success, easy performance and good repeatability . Previous studies have shown that CYPs exhibited essential functions in the metabolism of the majority of drugs .…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Nowadays, human liver microsomes (HLMs) are commonly used in in vitro drug metabolic studies with advantages of high probability of clinical success, easy performance and good repeatability . Previous studies have shown that CYPs exhibited essential functions in the metabolism of the majority of drugs .…”
mentioning
confidence: 99%
“…Nowadays, human liver microsomes (HLMs) are commonly used in in vitro drug metabolic studies with advantages of high probability of clinical success, easy performance and good repeatability. [39][40][41][42] Previous studies have shown that CYPs exhibited essential functions in the metabolism of the majority of drugs. [43][44][45][46][47] Meanwhile, high-resolution mass spectrometry (HRMS) is being used extensively in metabolic analyses owing to its accurate MS data and reliable metabolite identification when attempting to discriminate metabolites with different MS/MS fragments.…”
mentioning
confidence: 99%
“…It has been reported previously that N-oxidation is mainly mediated by FMO1/3 or P450s [20][21][22]. Greater insight into the enzymes involved in the formation and elimination of N-oxide metabolite might explain the contribution of FMO or P450s to metabolic eliminations of Y101 and the wide variability of Y101 pharmacokinetics in rats.…”
Section: 6metabolic Pathway In Ratsmentioning
confidence: 97%
“…administration to rats using the above five-step strategy in this study. As a consequence, a total of 30 metabolites were observed and Y101 was found to undergo amide hydrolysis, hydroxylation, mono-oxidation, di-oxidation, N-oxidation, methylation, demethylation, hydrogenation and glucuronidation in 21 rats. Proposed structures of all the detective metabolites and metabolic pathways in rats were shown in Fig.…”
Section: 6metabolic Pathway In Ratsmentioning
confidence: 99%
“…In terms of in vitro metabolic analysis of drugs, liver microsome was commonly used as an important alternative means to understand the drug metabolism with advantages of high probability of clinical success, easy performance and good repeatability . The human cytochrome P450s, which are rich in the liver, were believed to include a myriad of enzymatic reactions implicated in important life processes .…”
mentioning
confidence: 99%